Genfit SA (GNFT):企業の財務・戦略的SWOT分析

◆英語タイトル:Genfit SA (GNFT) - Financial and Strategic SWOT Analysis Review
◆商品コード:DATA904C15091
◆発行会社(調査会社):GlobalData
◆発行日:2019年3月
◆ページ数:25
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:フランス
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD300 ⇒換算¥44,400見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD600 ⇒換算¥88,800見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD900 ⇒換算¥133,200見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Genfit SA (Genfit) is a biopharmaceutical company that develops therapeutic and diagnostic solutions for metabolic and inflammatory diseases in liver and gastroenterology diseases. The company’s pipeline products include GFT505, biomarkers, TGFTX1 and TGFTX4. Its TGFTX1 is a research program for auto-immune and inflammatory diseases; and TGFTX4 for fibrotic diseases. Genfit develops diagnostic solutions in various therapeutic areas such as metabolic diseases, liver diseases, non-alcoholic steatohepatitis, cholestatic liver diseases, inflammation and autoimmune diseases, and inflammatory bowel diseases. The company’s research and development activities include multiple drug candidate research programs targeting novel mechanisms of action such as the inhibition of ROR?-t. It has presence in France and the US. Genfit is headquartered in Loos, France.

Genfit SA Key Recent Developments

Feb 04,2019: GENFIT: Reports full-year 2018 financial results: cash position of €207.2m as of 12.31.2018
Jan 04,2019: Genfit, Covance sign licensing agreement for NASH diagnostic test
Oct 23,2018: Genfit: Third quarter 2018 financial information
Oct 02,2018: GENFIT New data to be presented at 2018 AASLD meeting ahead of key results expected in 2018 and 2019
Sep 26,2018: GENFIT: further details on management changes

This comprehensive SWOT profile of Genfit SA provides you an in-depth strategic analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses and the potential opportunities and threats. The profile helps you formulate strategies that augment your business by enabling you to understand your partners, customers and competitors better.

This company report forms part of GlobalData’s ‘Profile on Demand’ service, covering over 50,000 of the world’s leading companies. Once purchased, GlobalData’s highly qualified team of company analysts will comprehensively research and author a full financial and strategic analysis of Genfit SA including a detailed SWOT analysis, and deliver this direct to you in pdf format within two business days. (excluding weekends).

The profile contains critical company information including*,

- Business description – A detailed description of the company’s operations and business divisions.
- Corporate strategy – Analyst’s summarization of the company’s business strategy.
- SWOT Analysis – A detailed analysis of the company’s strengths, weakness, opportunities and threats.
- Company history – Progression of key events associated with the company.
- Major products and services – A list of major products, services and brands of the company.
- Key competitors – A list of key competitors to the company.
- Key employees – A list of the key executives of the company.
- Executive biographies – A brief summary of the executives’ employment history.
- Key operational heads – A list of personnel heading key departments/functions.
- Important locations and subsidiaries – A list and contact details of key locations and subsidiaries of the company.
- Key manufacturing facilities – A list of key manufacturing facilities of the company.
- Detailed financial ratios for the past five years – The latest financial ratios derived from the annual financial statements published by the company with 5 years history.
- Interim ratios for the last five interim periods – The latest financial ratios derived from the quarterly/semi-annual financial statements published by the company for 5 interims history.

Note*: Some sections may be missing if data is unavailable for the company.

Key benefits of buying this profile include,

You get detailed information about the company and its operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, operations, major products and services, prospects, locations and subsidiaries, key executives and their biographies and key competitors.

Understand and respond to your competitors’ business structure and strategies, and capitalize on their weaknesses. Stay up to date on the major developments affecting the company.
- The company’s core strengths and weaknesses and areas of development or decline are analyzed and presented in the profile objectively. Recent developments in the company covered in the profile help you track important events.

Equip yourself with information that enables you to sharpen your strategies and transform your operations profitably.
- Opportunities that the company can explore and exploit are sized up and its growth potential assessed in the profile. Competitive and/or technological threats are highlighted.

Scout for potential investments and acquisition targets, with detailed insight into the companies’ strategic, financial and operational performance.
- Financial ratio presented for major public companies in the profile include the revenue trends, profitability, growth, margins and returns, liquidity and leverage, financial position and efficiency ratios.

Gain key insights into the company for academic or business research.
- Key elements such as SWOT analysis, corporate strategy and financial ratios and charts are incorporated in the profile to assist your academic or business research needs.

【レポートの目次】

Table of Contents

Section 1 – About the Company

Genfit SA – Key Information
Genfit SA – Overview
Genfit SA – Key Employees
Genfit SA – Key Employee Biographies
Genfit SA – Key Operational Heads
Genfit SA – Major Products and Services
Genfit SA – History
Genfit SA – Company Statement
Genfit SA – Locations And Subsidiaries
Genfit SA – Key Manufacturing facilities
Head Office
Other Locations & Subsidiaries

Section 2 – Company Analysis

Genfit SA – Business Description
Genfit SA – Corporate Strategy
Genfit SA – SWOT Analysis
SWOT Analysis – Overview
Genfit SA – Strengths
Genfit SA – Weaknesses
Genfit SA – Opportunities
Genfit SA – Threats
Genfit SA – Key Competitors

Section 3 – Company Financial Performance Charts

Genfit SA – Financial Ratios
Financial Ratios – Capital Market Ratios
Financial Ratios – Annual Ratios
Financial Ratios – Interim Ratios
Financial Ratios – Ratio Charts

Section 4 – Appendix

Appendix
Methodology
Ratio Definitions
About GlobalData
Contact Us
Disclaimer

Note*: Some sections may be missing if data is unavailable for the company

List of Tables

Genfit SA, Key Information
Genfit SA, Key Ratios
Genfit SA, Share Data
Genfit SA, Major Products and Services
Genfit SA, History
Genfit SA, Key Employees
Genfit SA, Key Employee Biographies
Genfit SA, Key Operational Heads
Genfit SA, Other Locations
Genfit SA, Subsidiaries
Genfit SA, Key Manufacturing facilities
Genfit SA, Key Competitors
Genfit SA, SWOT Analysis
Genfit SA, Ratios based on current share price
Genfit SA, Annual Ratios
Genfit SA, Interim Ratios
Currency Codes
Capital Market Ratios
Equity Ratios
Profitability Ratios
Cost Ratios
Liquidity Ratios
Leverage Ratios
Efficiency Ratios

List of Figures

Genfit SA, Performance Chart
Genfit SA, Ratio Charts

★海外企業調査レポート[Genfit SA (GNFT):企業の財務・戦略的SWOT分析]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • Healx Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Healx Ltd (Healx) is a provider of drug repurposing solutions and combinational medicines for advancing the treatment of rare diseases. The company’s technology combines biological data analysis with advanced machine learning algorithms to identify novel drug applications for rare diseases. …
  • Ascendance Biotechnology Inc:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascendance Biotechnology Inc (Ascendance), formerly Hepregen Corp is a healthcare products provider that offers cell based assay products. The company’s products include human HepatoMune kits, HepatoPac B-CLEAR transporter kits, human HepatoPac kits, rat HepatoPac kits, monkey HepatoPac kits …
  • Kennametal Inc.:戦略・SWOT・企業財務分析
    Kennametal Inc. - Strategy, SWOT and Corporate Finance Report Summary Kennametal Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corpo …
  • Industrija nafte d.d. (INA-R-A):石油・ガス:M&Aディール及び事業提携情報
    Summary Industrija nafte dd (INA) is an integrated energy company, which operates across the energy value chain from exploration and production to refining and marketing to retail. It has interests in offshore and onshore assets in Croatia, Egypt, and Angola. The company manages refineries in Rijeka …
  • Deloitte Touche Tohmatsu Ltd:企業の戦略的SWOT分析
    Deloitte Touche Tohmatsu Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major produc …
  • CHC Group Ltd:石油・ガス:M&Aディール及び事業提携情報
    Summary CHC Group Ltd (CHC) is a provider of helicopter services. The company offers various services including offshore transportation; search and rescue in challenging and hostile environments, from remote, perilous, and extreme terrains to offshore rescues; maintenance, repair, and overhaul; and …
  • Oryzon Genomics SA (ORY):企業の財務・戦略的SWOT分析
    Summary Oryzon Genomics SA (Oryzon) is a clinical stage biopharmaceutical company that offers discovers and develops epigenetic therapies to treat oncology and neurodegenerative diseases. The company offers epigenetics, a regulatory system that controls gene expression without affecting the makeup o …
  • Powszechny Zaklad Ubezpieczen Group:戦略・SWOT・企業財務分析
    Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report Summary Powszechny Zaklad Ubezpieczen Group - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, …
  • Crescendo Biologics Ltd:製薬・医療:M&Aディール及び事業提携情報
    Summary Crescendo Biologics Ltd (Crescendo) is a biopharmaceutical company that manufactures antibody therapeutics based on a transgenic mouse platform. The company’s pipeline includes humabody programs targeting oncology. It practises in the antibody discoveries and development, which include CAT, …
  • Euroclear Plc:企業の戦略・SWOT・財務分析
    Euroclear Plc - Strategy, SWOT and Corporate Finance Report Summary Euroclear Plc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and corporate …
  • Simcere Pharmaceutical Group:企業のM&A・事業提携・投資動向
    Simcere Pharmaceutical Group - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Simcere Pharmaceutical Group Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and a …
  • Enel Americas SA:企業の戦略・SWOT・財務情報
    Enel Americas SA - Strategy, SWOT and Corporate Finance Report Summary Enel Americas SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Maastricht University:医療機器:M&Aディール及び事業提携情報
    Summary Maastricht University (MU) is an educational service provider that offers academic programs such as bachelor degree, master and doctoral programs. The university offers postgraduate research degrees in various subjects for a range of research needs and interests. It offers programs through i …
  • LM Wind Power Holding AS:企業の戦略的SWOT分析
    LM Wind Power Holding AS - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products a …
  • PositiveID Corp (PSID):企業の財務・戦略的SWOT分析
    Summary PositiveID Corp (PositiveID), formerly VeriChip Corp is a life sciences tools and diagnostics company that develops biological detection and molecular diagnostic systems. The company develops microfluidic systems for automated preparation and performance of biological assays. Its products in …
  • VivaCell Biotechnology Espana SL:製薬・医療:M&Aディール及び事業提携情報
    Summary VivaCell Biotechnology Espana SL (VivaCell Biotechnology), a subsidiary of VivaCell Biotechnology GmbH, is a preclinical-stage pharmaceutical company that develops medicinal derivatives. The company's products comprise CDE-001, VCE-003.2 and VCE-004.8. It provides research and development, c …
  • UGL Ltd:企業の戦略的SWOT分析
    UGL Ltd - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major products and services. This …
  • Union des Groupements d’Achats Publics:企業の戦略的SWOT分析
    Union des Groupements d'Achats Publics - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and ma …
  • Intuitive Surgical Inc (ISRG):企業の財務・戦略的SWOT分析
    Intuitive Surgical Inc (ISRG) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakne …
  • Victrex plc (VCT):企業の財務・戦略的SWOT分析
    Summary Victrex Plc (Victrex) is a chemical company that manufactures and markets high-performance polymer materials and solutions. The company operates through its business units such as Victrex polymer solutions and Invibio biomaterial solutions. Its Victrex polymer solutions unit serves industria …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆